NORGINE
Live / Applied — Statement of use — registration review complete (as of 08 Dec 2025)
What this means for you
Not registered yet, but its 29 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97146661
- Mark type
- Design + words
- Filed
- 29 Nov 2021
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, laxatives, enema preparations, and intestinal lavage preparations; Pharmaceutical preparations for the diagnosis, prevention, alleviation and treatment of gastroenterology conditions and obstetrical conditions
Owner
- Velinor AG c/o Dr. iur. Adrian von Segesser, Luzern, CH
- Velinor AG c/o Dr. iur. Adrian von Segesser, Luzern, CH
Prosecution history
- 12 Dec 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 08 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2025 — DATA MODIFICATION COMPLETED
- 13 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jun 2025 — USE AMENDMENT FILED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 May 2025 — SOU EXTENSION 2 GRANTED
- 29 May 2025 — SOU EXTENSION 2 FILED
- 29 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2024 — SOU EXTENSION 1 GRANTED
- 02 Dec 2024 — SOU EXTENSION 1 FILED
- 02 Dec 2024 — SOU TEAS EXTENSION RECEIVED